Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This Study Will Evaluate Celecoxib Efficacy And Safety Versus Standard Doses Of Diclofenac In
Acute Pain Due To Cervical Injury (Due To A Sprain) Related To A Motor Vehicle Accident
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.